非酒精性脂肪性肝病药物治疗进展及认识

被引：5

作者：

张丹瑛

沈锡中

机构：

[1] 复旦大学附属中山医院消化科

来源：

世界临床药物 | 2013年 / 34卷 / 08期

关键词：

非酒精性脂肪性肝病; 代谢综合征; 胰岛素抵抗; 药物治疗;

D O I：

暂无

中图分类号：

R575.5 [肝代谢障碍];

学科分类号：

100201 [内科学];

摘要：

非酒精性脂肪性肝病(NAFLD)是西方国家慢性肝病的首要病因。当代人们不良生活习惯增多,NAFLD的全球发病率逐年增高,我国也有相应增高。临床治疗NAFLD的药物包括降脂药、减肥药、胰岛素增敏剂和抗氧化剂等。本文综述NAFLD的药物治疗进展及认识。

引用

页码：449 / 453

页数：5

共 20 条

[1]

Silymarin in non alcoholic fatty liver disease [J].

Cacciapuoti, Fulvio ;

Scognamiglio, Anna ;

Palumbo, Rossella ;

Forte, Raffaele ;

Cacciapuoti, Federico .

WORLD JOURNAL OF HEPATOLOGY, 2013, 5 (03) :109-113

[2]

肝脏脂肪沉积是代谢紊乱的启动因素 [J].

高鑫 .

中华医学杂志, 2011, (26)

[3]

非酒精性脂肪性肝病诊疗指南(2010年修订版) [J].

中华医学会肝病学分会脂肪肝和酒精性肝病学组 ;

范建高 .

中华肝脏病杂志, 2010, (03)

[4]

Improved oxidative stress and cardio-metabolic status in obese prepubertal children with liver steatosis treated with lifestyle combined with Vitamin E [J].

D'Adamo, E. ;

Marcovecchio, M. L. ;

Giannini, C. ;

de Giorgis, T. ;

Chiavaroli, V. ;

Chiarelli, F. ;

Mohn, A. .

FREE RADICAL RESEARCH, 2013, 47 (03) :146-153

[5]

Adipose tissue is inflamed in NAFLD due to obesity but not in NAFLD due to genetic variation in PNPLA3 [J].

Lallukka, S. ;

Sevastianova, K. ;

Perttila, J. ;

Hakkarainen, A. ;

Orho-Melander, M. ;

Lundbom, N. ;

Olkkonen, V. M. ;

Yki-Jarvinen, H. .

DIABETOLOGIA, 2013, 56 (04) :886-892

[6]

A moderate weight reduction through dietary intervention decreases hepatic fat content in patients with non-alcoholic fatty liver disease (NAFLD): a pilot study [J].

Volynets, Valentina ;

Machann, Juergen ;

Kueper, Markus A. ;

Maier, Ina B. ;

Spruss, Astrid ;

Koenigsrainer, Alfred ;

Bischoff, Stephan C. ;

Bergheim, Ina .

EUROPEAN JOURNAL OF NUTRITION, 2013, 52 (02) :527-535

[7]

Anti-oxidant therapy in non-alcoholic fatty liver disease: the role of silymarin [J].

Abenavoli, Ludovico ;

Milic, Natasa ;

Capasso, Francesco .

ENDOCRINE, 2012, 42 (03) :754-755

[8]

Atorvastatin improves disease activity of nonalcoholic steatohepatitis partly through its tumour necrosis factor-α-lowering property.[J].Hideyuki Hyogo;Sho-ichi Yamagishi;Sayaka Maeda;Yuki Kimura;Tomokazu Ishitobi;Kazuaki Chayama.Digestive and Liver Disease.2011, 6

[9]

Fatty liver induced by free radicals and lipid peroxidation [J].